病院薬学
Online ISSN : 2185-9477
Print ISSN : 0389-9098
ISSN-L : 0389-9098
マクロライド系抗生物質による相互作用誘発危険性の比較評価
各種文献データの遡及的統合
大谷 壽一川端 志津矢崎 裕美子小瀧 一澤田 康文伊賀 立二
著者情報
ジャーナル フリー

1998 年 24 巻 3 号 p. 214-220

詳細
抄録
Although macrolide antibiotics are known to elicit a pharmacokinetic interaction with other various agents via the inhibition of oxidative metabolism by P 450, the inducibilities of druginteraction have yet to be quantitatively compared among various macrolides. To quantitatively compare these incidences, we collected the findings of various reports in order to analyze and integrate them retrospectively
.We chosed reports referring to the area under the curve (AUC) value in human after the oral administration of carbamazepine, cyclosporine, felodipine, midazolam or terfenadine, which is known to be metabolized by P 450 3 A 4, alone and with macrolides. The decreases in oral clearance (ΔCLp. o.) evoked by macrolides were calculated according to the increase in AUC by the concomitant administration of macrolides.
In the 23 collected reports, erythromycin (EM), clarithromycin (CAM), azithromycin (AZM), miocamycin (MDM) and roxithromycin (RXM) were referred to in 13, 2, 6, 2 and 2 reports, respectively. Other macrolides, were only referred to in one report. The ACLp.o. values of the five macrolides noted above, i. e. EM, CAM, AZM, MDM and RXM were 51.0±18.1, 66.3±8.1, 5.8±13.6, 29.4±23.5 and 11.1±29.5%(mean±S. D.), respectively. The ACLp. o. that of AZM was significantly smaller than of EM and CAM (p< 0.001 and p< 0.01, respectively ; by ANOVA and Bonferroni multiple comparison test).
In conclusion, based on a retrospective analysis of the pharmacokinetic data in literature, AZM may be less effective for eliciting a pharmacokinetic drug-interaction. As a result, AZM might have some advantages over EM or CAM for avoiding of drug-interaction.
著者関連情報
© 一般社団法人 日本医療薬学会
前の記事 次の記事
feedback
Top